PortalPublikationenSymmetric dimethylarginine predicts all-cause mortality foll...

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

Standard

Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. / Schulze, Friedrich; Carter, Angela M; Schwedhelm, Edzard; Ajjan, Ramzi; Maas, Renke; von Holten, Rouven-Alexander; Atzler, Dorothee; Grant, Peter J; Böger, Rainer.

in: ATHEROSCLEROSIS, Jahrgang 208, Nr. 2, 2, 2010, S. 518-523.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Schulze, F, Carter, AM, Schwedhelm, E, Ajjan, R, Maas, R, von Holten, R-A, Atzler, D, Grant, PJ & Böger, R 2010, 'Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.', ATHEROSCLEROSIS, Jg. 208, Nr. 2, 2, S. 518-523. <http://www.ncbi.nlm.nih.gov/pubmed/19700158?dopt=Citation>

APA

Schulze, F., Carter, A. M., Schwedhelm, E., Ajjan, R., Maas, R., von Holten, R-A., Atzler, D., Grant, P. J., & Böger, R. (2010). Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. ATHEROSCLEROSIS, 208(2), 518-523. [2]. http://www.ncbi.nlm.nih.gov/pubmed/19700158?dopt=Citation

Vancouver

Schulze F, Carter AM, Schwedhelm E, Ajjan R, Maas R, von Holten R-A et al. Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke. ATHEROSCLEROSIS. 2010;208(2):518-523. 2.

Bibtex

@article{ee997a40343e4c4b957605ab95a9e088,
title = "Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.",
abstract = "OBJECTIVE: Methylarginines have been shown to interfere with nitric oxide (NO) formation by inhibiting NO synthase (asymmetric dimethylarginine, ADMA, and monomethylarginine, NMMA) and the cellular l-arginine uptake system (ADMA, NMMA and symmetric dimethylarginine, SDMA), thereby causing endothelial dysfunction. ADMA is a predictor of cardiovascular events and mortality in diverse populations. METHODS: We investigated whether methylarginines are predictors of mortality in 394 patients after acute ischemic stroke during 7.4 years of follow-up. RESULTS: Patients who died (N=231) were older and more frequently had one of the traditional risk factors for stroke (previous stroke/TIA, atrial fibrillation, prevalent ischemic heart disease, peripheral vascular disease, each p",
author = "Friedrich Schulze and Carter, {Angela M} and Edzard Schwedhelm and Ramzi Ajjan and Renke Maas and {von Holten}, Rouven-Alexander and Dorothee Atzler and Grant, {Peter J} and Rainer B{\"o}ger",
year = "2010",
language = "Deutsch",
volume = "208",
pages = "518--523",
journal = "ATHEROSCLEROSIS",
issn = "0021-9150",
publisher = "Elsevier Ireland Ltd",
number = "2",

}

RIS

TY - JOUR

T1 - Symmetric dimethylarginine predicts all-cause mortality following ischemic stroke.

AU - Schulze, Friedrich

AU - Carter, Angela M

AU - Schwedhelm, Edzard

AU - Ajjan, Ramzi

AU - Maas, Renke

AU - von Holten, Rouven-Alexander

AU - Atzler, Dorothee

AU - Grant, Peter J

AU - Böger, Rainer

PY - 2010

Y1 - 2010

N2 - OBJECTIVE: Methylarginines have been shown to interfere with nitric oxide (NO) formation by inhibiting NO synthase (asymmetric dimethylarginine, ADMA, and monomethylarginine, NMMA) and the cellular l-arginine uptake system (ADMA, NMMA and symmetric dimethylarginine, SDMA), thereby causing endothelial dysfunction. ADMA is a predictor of cardiovascular events and mortality in diverse populations. METHODS: We investigated whether methylarginines are predictors of mortality in 394 patients after acute ischemic stroke during 7.4 years of follow-up. RESULTS: Patients who died (N=231) were older and more frequently had one of the traditional risk factors for stroke (previous stroke/TIA, atrial fibrillation, prevalent ischemic heart disease, peripheral vascular disease, each p

AB - OBJECTIVE: Methylarginines have been shown to interfere with nitric oxide (NO) formation by inhibiting NO synthase (asymmetric dimethylarginine, ADMA, and monomethylarginine, NMMA) and the cellular l-arginine uptake system (ADMA, NMMA and symmetric dimethylarginine, SDMA), thereby causing endothelial dysfunction. ADMA is a predictor of cardiovascular events and mortality in diverse populations. METHODS: We investigated whether methylarginines are predictors of mortality in 394 patients after acute ischemic stroke during 7.4 years of follow-up. RESULTS: Patients who died (N=231) were older and more frequently had one of the traditional risk factors for stroke (previous stroke/TIA, atrial fibrillation, prevalent ischemic heart disease, peripheral vascular disease, each p

M3 - SCORING: Zeitschriftenaufsatz

VL - 208

SP - 518

EP - 523

JO - ATHEROSCLEROSIS

JF - ATHEROSCLEROSIS

SN - 0021-9150

IS - 2

M1 - 2

ER -